OBJECTIVES: To determine the causal effects of an intervention proven effective in pre-post studies in reducing central line-associated bloodstream infections in the intensive care unit. DESIGN: We conducted a multicenter, phased, cluster-randomized controlled trial in which hospitals were randomized into two groups. The intervention group started in March 2007 and the control group started in October 2007; the study period ended September 2008. Baseline data for both groups are from 2006. SETTING: Forty-five intensive care units from 35 hospitals in two Adventist healthcare systems. INTERVENTIONS: A multifaceted intervention involving evidence-based practices to prevent central line-associated bloodstream infections and the Comprehensive Unit-based Safety Program to improve safety, teamwork, and communication. MEASUREMENTS AND RESULTS: We measured central line-associated bloodstream infections per 1,000 central line days and reported quarterly rates. Baseline average central line-associated bloodstream infections per 1,000 central line days was 4.48 and 2.71, for the intervention and control groups (p = .28), respectively. By October to December 2007, the infection rate declined to 1.33 in the intervention group compared to 2.16 in the control group (adjusted incidence rate ratio 0.19; p = .003; 95% confidence interval 0.06-0.57). The intervention group sustained rates <1/1,000 central line days at 19 months (an 81% reduction). The control group also reduced infection rates to <1/1,000 central line days (a 69% reduction) at 12 months. CONCLUSIONS: This study demonstrated a causal relationship between the multifaceted intervention and the reduced central line-associated bloodstream infections. Both groups decreased infection rates after implementation and sustained these results over time, replicating the results found in previous, pre-post studies of this multifaceted intervention and providing further evidence that most central line-associated bloodstream infections are preventable.
RCT Entities:
OBJECTIVES: To determine the causal effects of an intervention proven effective in pre-post studies in reducing central line-associated bloodstream infections in the intensive care unit. DESIGN: We conducted a multicenter, phased, cluster-randomized controlled trial in which hospitals were randomized into two groups. The intervention group started in March 2007 and the control group started in October 2007; the study period ended September 2008. Baseline data for both groups are from 2006. SETTING: Forty-five intensive care units from 35 hospitals in two Adventist healthcare systems. INTERVENTIONS: A multifaceted intervention involving evidence-based practices to prevent central line-associated bloodstream infections and the Comprehensive Unit-based Safety Program to improve safety, teamwork, and communication. MEASUREMENTS AND RESULTS: We measured central line-associated bloodstream infections per 1,000 central line days and reported quarterly rates. Baseline average central line-associated bloodstream infections per 1,000 central line days was 4.48 and 2.71, for the intervention and control groups (p = .28), respectively. By October to December 2007, the infection rate declined to 1.33 in the intervention group compared to 2.16 in the control group (adjusted incidence rate ratio 0.19; p = .003; 95% confidence interval 0.06-0.57). The intervention group sustained rates <1/1,000 central line days at 19 months (an 81% reduction). The control group also reduced infection rates to <1/1,000 central line days (a 69% reduction) at 12 months. CONCLUSIONS: This study demonstrated a causal relationship between the multifaceted intervention and the reduced central line-associated bloodstream infections. Both groups decreased infection rates after implementation and sustained these results over time, replicating the results found in previous, pre-post studies of this multifaceted intervention and providing further evidence that most central line-associated bloodstream infections are preventable.
Authors: Alisa Khan; Nancy D Spector; Jennifer D Baird; Michele Ashland; Amy J Starmer; Glenn Rosenbluth; Briana M Garcia; Katherine P Litterer; Jayne E Rogers; Anuj K Dalal; Stuart Lipsitz; Catherine S Yoon; Katherine R Zigmont; Amy Guiot; Jennifer K O'Toole; Aarti Patel; Zia Bismilla; Maitreya Coffey; Kate Langrish; Rebecca L Blankenburg; Lauren A Destino; Jennifer L Everhart; Brian P Good; Irene Kocolas; Rajendu Srivastava; Sharon Calaman; Sharon Cray; Nicholas Kuzma; Kheyandra Lewis; E Douglas Thompson; Jennifer H Hepps; Joseph O Lopreiato; Clifton E Yu; Helen Haskell; Elizabeth Kruvand; Dale A Micalizzi; Wilma Alvarado-Little; Benard P Dreyer; H Shonna Yin; Anupama Subramony; Shilpa J Patel; Theodore C Sectish; Daniel C West; Christopher P Landrigan Journal: BMJ Date: 2018-12-05
Authors: E Yoko Furuya; Andrew W Dick; Carolyn T A Herzig; Monika Pogorzelska-Maziarz; Elaine L Larson; Patricia W Stone Journal: Infect Control Hosp Epidemiol Date: 2016-04-07 Impact factor: 3.254
Authors: Natalie M Pageler; Christopher A Longhurst; Matthew Wood; David N Cornfield; Jaap Suermondt; Paul J Sharek; Deborah Franzon Journal: Pediatrics Date: 2014-02-24 Impact factor: 7.124
Authors: Bo Zhu; Zhiqiang Li; Li Jiang; Bin Du; Qi Jiang; Meiping Wang; Ran Lou; Xiuming Xi Journal: Intensive Care Med Date: 2015-07-09 Impact factor: 17.440
Authors: Frank Bloos; Hendrik Rüddel; Daniel Thomas-Rüddel; Daniel Schwarzkopf; Christine Pausch; Stephan Harbarth; Torsten Schreiber; Matthias Gründling; John Marshall; Philipp Simon; Mitchell M Levy; Manfred Weiss; Andreas Weyland; Herwig Gerlach; Tobias Schürholz; Christoph Engel; Claudia Matthäus-Krämer; Christian Scheer; Friedhelm Bach; Reimer Riessen; Bernhard Poidinger; Karin Dey; Norbert Weiler; Andreas Meier-Hellmann; Helene H Häberle; Gabriele Wöbker; Udo X Kaisers; Konrad Reinhart Journal: Intensive Care Med Date: 2017-05-02 Impact factor: 17.440
Authors: Nishi Rawat; Ting Yang; Kisha J Ali; Mary Catanzaro; Mariah D Cohen; Donna O Farley; Lisa H Lubomski; David A Thompson; Bradford D Winters; Sara E Cosgrove; Michael Klompas; Kathleen A Speck; Sean M Berenholtz Journal: Crit Care Med Date: 2017-07 Impact factor: 7.598
Authors: Kerri A Thom; Shanshan Li; Melissa Custer; Michael Anne Preas; Cindy D Rew; Christina Cafeo; Surbhi Leekha; Brian S Caffo; Thomas M Scalea; Matthew E Lissauer Journal: Am J Infect Control Date: 2013-12-17 Impact factor: 2.918